Allison Wey | Senior Vice President of Investor Relations and Corporate Communications |
Paul Edick | Chairman and Chief Executive Officer |
Steve Pieper | Chief Financial Officer |
Roanna Ruiz | SVB Securities |
Oren Livnat | H.C. Wainwright |
David Amsellem | Piper Sandler |
Hello, and welcome to today’s Xeris Biopharma’s Second Quarter 2022 Financial Results Conference Call. My name is Aliet and I will be coordinating your call today. [Operator Instructions] I would now like to hand over to Allison Wey, Senior Vice President of Investor Relations and Corporate Communications. The floor is yours. please go ahead.